The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.
about
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer17β-estradiol represses myogenic differentiation by increasing ubiquitin-specific peptidase 19 through estrogen receptor αERbeta in breast cancer--onlooker, passive player, or active protector?ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancerExpression and prognostic value of estrogen receptor beta in breast cancer patients.Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sitesEstrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifenObesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated PathwayImpact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.Estrogen receptor-beta and breast cancer: translating biology into clinical practiceExpression of estrogen-induced genes and estrogen receptor β in pancreatic neuroendocrine tumors: implications for targeted therapySynthesis and biological evaluation of two agents for imaging estrogen receptor β by positron emission tomography: challenges in PET imaging of a low abundance target.Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours.Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancerTARGETING THE GENOTOXIC EFFECTS OF ESTROGENS.Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis.Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody.Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cellsTargeting the androgen receptor in breast cancer.Steroid hormone receptors as prognostic markers in breast cancer.Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma.Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer.Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2.Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow?Prognostic Significance of High Expression of ER-beta in Surgically Treated ER-Positive Breast Cancer Following Endocrine Therapy.The evolving role of oestrogen receptor beta in clinical breast cancer.Potential clinical significance of ERβ ON promoter methylation in sporadic breast cancer.Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma.ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer.Expression of wild-type estrogen receptor beta protein in human breast cancer: specific correlation with HER2/neu overexpression.Evaluation of ER-α, ER-Β1 and ER-Β2 expression and correlation with clinicopathologic factors in invasive luminal subtype breast cancers.ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function.
P2860
Q26773907-AF4A9EFB-2D60-484E-AD6C-3B861FD67AF3Q28512427-E6A2EFFC-4F84-4F8D-AD20-915DDABFD140Q30438399-012712D4-DD09-4457-8268-961C18D6F928Q34334131-DAE52A60-B12A-42FC-A62C-2DEDA7C98288Q34547653-8FE4635B-8843-418E-B1B9-D6339E102360Q34663257-F891B1ED-FBEE-4D82-AD64-1CF3A6F9EE7CQ35179559-F61627AB-6625-4CDA-9CD7-45A305B13666Q35558946-4CE12CE7-133F-4910-9334-FC5315C7D1A4Q35879517-7DD5010D-9376-4F73-8274-3F4F14BF37CAQ35931634-43FDCA51-9288-493C-A2BB-BEF7C7B55D82Q35973424-812A6AE5-3C4C-4208-BBC8-54D32141A5A8Q36236672-BB786929-D98D-4DE1-BB02-8A73D92B198CQ36301166-FF2426C1-10C2-474C-928D-F88751A2538CQ36612259-F21EE912-C3FE-4A76-8CBC-2FE6DCD266D2Q36695908-46E7A2B7-AFE6-444D-910C-14B82DEFEFD9Q36936984-4DF45F88-94F0-4F86-889B-293354C0B955Q36962972-D6A0CAB2-D405-4F38-8AE2-CD0CA42C94D9Q37049590-27F4731C-CBB5-47A9-80A4-5636B444207CQ37624907-E5A275FE-3B0C-41BA-907E-0F8228EBC891Q38349376-536541A2-5A96-41A8-91F1-D14CB03A2873Q38598704-5FB3B333-2C77-4F85-A4A0-A76D731D2245Q39253863-C0ADA090-180F-4E5D-A6BE-E8FFEC15BA65Q39434758-1E631896-9575-4DC1-AAA8-D0BEF7B387DBQ39625460-05AFF187-CA8F-42F3-A4B9-80703B667EB6Q41273764-DC4B84F0-0BA0-4BEC-BBED-E3248E7A32EAQ41780559-FA5468CF-8777-4A72-BE18-A714AD523CECQ43212160-7DB2851A-E385-4AF7-891D-5652D60D1534Q43571053-04AFD9E3-93CE-4BE9-9E1A-092C2A64B9B8Q44380247-040B5AE1-0134-4BC0-A6FB-1B5515C78043Q47134638-87EDDC55-546C-42A8-8F89-2770763F3BD7Q51155024-52B97946-47CF-495A-A324-54A108D2EC7BQ51412868-FBCBC9A8-CC7E-4985-8F5E-13B14DB2D456Q55421291-4ECDD8B7-443D-4F37-91A7-3B20E8D8CDB1
P2860
The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The favourable prognostic valu ...... l expression in breast cancer.
@ast
The favourable prognostic valu ...... l expression in breast cancer.
@en
type
label
The favourable prognostic valu ...... l expression in breast cancer.
@ast
The favourable prognostic valu ...... l expression in breast cancer.
@en
prefLabel
The favourable prognostic valu ...... l expression in breast cancer.
@ast
The favourable prognostic valu ...... l expression in breast cancer.
@en
P2093
P2860
P356
P1476
The favourable prognostic valu ...... l expression in breast cancer.
@en
P2093
A C Lazaris
A Keramopoulos
E G Panayotopoulou
I Giannopoulou
L Nakopoulou
P2860
P304
P356
10.1136/JCP.2003.008599
P407
P577
2004-05-01T00:00:00Z